Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test new prostate drugs in healthy volunteers

NCT ID NCT07444385

Summary

This early-stage study aims to check the safety and measure how the body absorbs and processes two new drugs (AD-116 and AD-1161) for an enlarged prostate (BPH). It involves 44 healthy adult male volunteers who will take single doses of the drugs after eating. The main goal is to see how the drugs move through the body and to monitor for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • H PLUS YANGJI HOSPITAL, Seoul

    RECRUITING

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.